Nisa Investment Advisors LLC cut its position in Albemarle Co. (NYSE:ALB) by 0.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 58,320 shares of the specialty chemicals company’s stock after selling 500 shares during the quarter. Nisa Investment Advisors LLC owned approximately 0.05% of Albemarle worth $7,459,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Neuberger Berman Group LLC raised its stake in Albemarle by 43.5% during the 2nd quarter. Neuberger Berman Group LLC now owns 13,701 shares of the specialty chemicals company’s stock valued at $1,446,000 after acquiring an additional 4,154 shares during the last quarter. Schroder Investment Management Group raised its stake in Albemarle by 120.5% during the 2nd quarter. Schroder Investment Management Group now owns 40,350 shares of the specialty chemicals company’s stock valued at $4,223,000 after acquiring an additional 22,050 shares during the last quarter. Private Advisor Group LLC raised its stake in Albemarle by 20.8% during the 2nd quarter. Private Advisor Group LLC now owns 2,412 shares of the specialty chemicals company’s stock valued at $267,000 after acquiring an additional 415 shares during the last quarter. AXA raised its stake in Albemarle by 4.4% during the 2nd quarter. AXA now owns 3,550 shares of the specialty chemicals company’s stock valued at $374,000 after acquiring an additional 150 shares during the last quarter. Finally, Alliancebernstein L.P. raised its stake in Albemarle by 1.3% during the 2nd quarter. Alliancebernstein L.P. now owns 197,367 shares of the specialty chemicals company’s stock valued at $20,830,000 after acquiring an additional 2,495 shares during the last quarter. 88.07% of the stock is owned by hedge funds and other institutional investors.

ALB has been the subject of several analyst reports. Loop Capital initiated coverage on Albemarle in a research note on Thursday, September 28th. They set a “buy” rating and a $150.00 price objective for the company. Royal Bank of Canada reaffirmed a “buy” rating and set a $149.00 price objective on shares of Albemarle in a research note on Wednesday, October 18th. Nomura upped their price objective on Albemarle from $146.00 to $154.00 and gave the company a “buy” rating in a research note on Tuesday, October 10th. Robert W. Baird reaffirmed a “hold” rating and set a $135.00 price objective on shares of Albemarle in a research note on Wednesday, November 1st. Finally, Oppenheimer upped their price objective on Albemarle from $133.00 to $157.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. Ten equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $128.38.

Albemarle Co. (NYSE ALB) opened at $133.52 on Monday. The stock has a market capitalization of $14,753.37, a P/E ratio of 17.27, a PEG ratio of 1.75 and a beta of 1.69. Albemarle Co. has a one year low of $90.35 and a one year high of $144.99. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.56 and a current ratio of 2.11.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.01. The business had revenue of $755.00 million during the quarter, compared to the consensus estimate of $732.19 million. Albemarle had a return on equity of 11.61% and a net margin of 30.07%. The company’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 EPS. research analysts anticipate that Albemarle Co. will post 4.46 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, January 2nd. Stockholders of record on Friday, December 15th were paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.96%. The ex-dividend date of this dividend was Thursday, December 14th. Albemarle’s dividend payout ratio (DPR) is 16.56%.

ILLEGAL ACTIVITY NOTICE: “Albemarle Co. (ALB) Shares Sold by Nisa Investment Advisors LLC” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/01/15/albemarle-co-alb-shares-sold-by-nisa-investment-advisors-llc.html.

Albemarle Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Stock Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related stocks with our FREE daily email newsletter.